Showing results (1511-1520 of 1,852) with videos related to

Sort By:
Pageof 186
Cancer Chemotherapy and Pharmacology|July 26, 2018
The risk factors for oxaliplatin-induced peripheral sensory neuropathy and thrombocytopenia in advanced gastric cancerKyoko Yamaguchi, Hitoshi Kusaba, Akitaka Makiyama, et al.
Heart and Vessels|September 30, 2023
Habitual isomaltulose intake reduces arterial stiffness associated with postprandial hyperglycemia in middle-aged and elderly people: a randomized controlled trialRyota Kobayashi, Miki Sakazaki, Yukie Nagai, et al.
Journal of Neuropathology and Experimental Neurology|June 18, 2015
Targeting Hypoxia-Inducible Factor 1α in a New Orthotopic Model of Glioblastoma Recapitulating the Hypoxic Tumor MicroenvironmentFares Nigim, Jill Cavanaugh, Anoop P Patel, et al.
Aging|September 16, 2021
Metformin-induced chemosensitization to cisplatin depends on P53 status and is inhibited by Jarid1b overexpression in non-small cell lung cancer cellsTharcisio Citrangulo Tortelli, Rodrigo Esaki Tamura, Mara de Souza Junqueira, et al.
Journal of Gastroenterology and Hepatology|February 18, 2021
Factors associated with inaccurate size estimation of colorectal polyps: A multicenter cross-sectional studyTakahiro Utsumi, Takahiro Horimatsu, Yoshitaka Nishikawa, et al.
Cancer Gene Therapy|September 4, 2019
Oncolytic activity of HF10 in head and neck squamous cell carcinomasShinichi Esaki, Fumi Goshima, Haruka Ozaki, et al.
Journal for Immunotherapy of Cancer|August 16, 2019
Safety, tolerability, pharmacokinetics, and pharmacodynamics of the afucosylated, humanized anti-EPHA2 antibody DS-8895a: a first-in-human phase I dose escalation and dose expansion study in patients with advanced solid tumorsKohei Shitara, Taroh Satoh, Satoru Iwasa, et al.
Gastrointestinal Endoscopy|December 2, 2022
Auxiliary diagnosis of subepithelial lesions by impedance measurement during EUS-guided fine-needle biopsyYosuke Minoda, Mitsuru Esaki, Eikichi Ihara, et al.
Oncology|May 22, 2013
Concurrent chemoradiotherapy with a novel fluoropyrimidine, S-1, and cisplatin for locally advanced esophageal cancer: long-term results of a phase II trialHiroaki Iwase, Masaaki Shimada, Tomoyuki Tsuzuki, et al.
British Journal of Cancer|September 19, 2013
Randomised phase II study of S-1/cisplatin plus TSU-68 vs S-1/cisplatin in patients with advanced gastric cancerW Koizumi, K Yamaguchi, H Hosaka, et al.
Pageof 186